Reach7 Diabetes Studio

Reach7 Diabetes Studios: The First Concierge Franchise for Diabetes and Weight Management

The Market Opportunity: The U.S. is facing a massive metabolic crisis with over 40 million Americans living with diabetes and 100 million struggling with obesity. At the same time, a severe national shortage of endocrinologists has created 6-to-12 month wait times for patients desperately seeking care. Reach7 Diabetes Studios is capturing this massive, underserved market as the first membership-based, retail franchise dedicated exclusively to diabetes, prediabetes, and weight management.

The Business Model: Reach7 operates on a highly lucrative, $299/month cash-pay membership model. For franchisees, this means immediate, predictable recurring revenue with zero reliance on insurance reimbursements, claim denials, or administrative "red tape". Our modern studios require a small, cost-effective retail footprint (1,400–1,600 sq ft) and are strategically located next to high-traffic anchors like Publix grocery stores to drive organic walk-in visibility. Because of the recurring revenue structure, a typical studio only needs about 300 members to achieve profitability.

The "Unfair Advantage":

• Proprietary AI Technology: Our proprietary clinical decision support software (Diasyst) empowers mid-level practitioners (Nurse Practitioners and Physician Assistants) to safely deliver specialist-level outcomes. This completely removes the primary barrier to scaling healthcare: the need to hire scarce, expensive specialists.

• First-Mover Status: There is currently no direct franchise competition in this specific "medical-to-retail" space. Franchisees are getting in at the ground level of a category-defining brand.

• "Phygital" Scale: We combine the high-touch accountability of in-person retail visits with a highly scalable 24/7 remote biometric monitoring system, creating incredible patient "stickiness," exceptional clinical outcomes, and long-term retention.
Ideal Franchisees: Reach7 provides a fully turnkey, asset-light investment opportunity ideal for:

• Medical Providers (MDs, DOs, NPs, PAs) looking to own their own independent practice, escape the burnout of the insurance system, and monetize their existing patient panels.

• Business Executives & Investors seeking a recession-resistant, high-margin asset with proven operational playbooks and a recurring revenue stream.

• Existing Healthcare Owners (e.g., urgent care, dialysis centers, or retinal surgeons) who want a synergistic business where they can refer their existing diabetic patients.
Reach7 isn't just another clinic; it is a scalable, tech-enabled platform poised to redefine chronic care while delivering exceptional unit economics for its franchise partners.